Amivantamab plus Chemotherapy: A New Treatment Option for EGFR Exon 20 Insertion Mutations in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Johnson & Johnson

doi:10.26303/9dvt-x685

	
		OSZAR »